Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Intervention Indication Therapeutic Area Year Actions
Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps Tezepelumab (AMG 157; MEDI9929) Nasal polyps , Rhinosinusitis Ear Nose and Throat (ENT) 2023 View  |  Download
Tenecteplase for treating acute ischaemic stroke Tenecteplase Acute ischaemic stroke Cardiovascular System 2023 View  |  Download
Telisotuzumab vedotin for previously treated c-MET overexpressing EGFR wild-type non-squamous non-small cell lung cancer Telisotuzumab vedotin (ABBV-399;ABBV 399;ABBV399;ABT-399;Teliso-V) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Tazemetostat for treating relapsed or refractory
follicular lymphoma after two therapies
Tazemetostat (E7438;EPZ-6438;Tazverik) Follicular lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
TAS-102 with bevacizumab for treating refractory metastatic colorectal cancer after 2 previous therapies Bevacizumab (Avastin; R 435; RG 405; RG 435) , Lonsurf; TAS-102 (fixed dose combination: Trifluridine; Tipiracil hydrochloride) Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Tarlatamab for relapsed/refractory small-cell lung cancer Tarlatamab Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2023 View  |  Download
Tafasitamab with lenalidomide as add-on therapy for previously treated follicular lymphoma or marginal zone lymphoma Lenalidomide (Revlimid) , Tafasitamab (MOR208; Monjuvi) Follicular lymphoma , Marginal zone lymphoma (MZL) Haematological Cancer and Lymphomas 2023 View  |  Download
Subcutaneous isatuximab with pomalidomide and dexamethasone for treating relapsed and/or refractory multiple myeloma Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst) , Subcutaneous isatuximab Multiple myeloma (MM) Haematological Cancer and Lymphomas 2023 View  |  Download
Sparsentan for treating primary IgA nephropathy Sparsentan (RE-021; PS433540) IgA nephropathy Immunology , Nephrology 2023 View  |  Download
Sirolimus-eluting collagen implant for preventing vascular access failure in end stage renal disease patients undergoing haemodialysis Sirolimus-eluting collagen implant Renal disease Cardiovascular System , Immunology 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications